Chinese companies and the UPC: from enforcement targets to strategic users

​
August 13, 2026

The Unified Patent Court (UPC) recently published its 2025 Annual Report, offering a useful snapshot of the court’s development during its second full year of operation. Interestingly, the report highlights the growing prominence of Chinese parties in UPC litigation.

Among infringement actions, China ranks third by claimant origin following Germany and the United States, and fourth by defendant nationality following Germany, The Netherlands and France, underscoring the increasing importance of Chinese companies within the UPC system.

The annual report, however, does not provide a detailed analysis of Chinese participation in patent infringement proceedings. To address that gap, this article undertakes an independent review of all patent infringement actions filed before the UPC Court of First Instance during 2025.

Using the UPC's public case search tool, each infringement action was reviewed individually to identify cases involving at least one Chinese party and to record the relevant technology sector, procedural venue and party position.

The review identified 253 infringement actions recorded in the UPC public case search tool for 2025, of which 97 involved at least one Chinese party.

Chinese parties therefore appeared in approximately 38% of the visible infringement docket.

Chinese-party share of the 2025 UPC infringement docket
0 50 100 150 200 250 Chinese party 97 cases · 38% No Chinese party 156 cases · 62%

The figures confirm that Chinese companies are now among the most frequent participants in UPC litigation. More importantly, they suggest that Chinese companies are transitioning from being primarily enforcement targets to becoming increasingly sophisticated users of the system.

Chinese companies predominantly defendants

The most immediate observation is that Chinese companies continue to be on there receiving end of infringement litigation more often than they act as claimants. Among the 97 cases involving Chinese parties, 84 involved at least one Chinese defendant. Twenty involved a Chinese claimant, including seven disputes in which both claimant and defendant were Chinese entities.

How Chinese parties appeared across the 97 cases
0 20 40 60 80 Defendant only 77 cases Claimant only 13 cases Both Chinese 7 cases

Many of the defendants operate in sectors characterised by intensive patent licensing and enforcement activity, particularly telecommunications, consumer electronics and connected devices.

The data also reveal repeated enforcement campaigns against a relatively small group of companies, including Xiaomi, Transsion, Huawei, OPPO, vivo, BYD, TCL and Hisense. This pattern is consistent with broader global trends in which major operating companies and licensing entities pursue portfolio-based litigation strategies against significant market participants.

Repeat Chinese defendants named in the 2025 UPC docket
Xiaomi
Transsion
Huawei
OPPO
vivo
BYD
TCL
Hisense

For rightsholders, the UPC's ability to deliver remedies covering multiple European jurisdictions through a single action makes it an attractive forum for such campaigns.

For Chinese companies with substantial European operations, the UPC has therefore become a significant litigation risk requiring strategic attention rather than merely reactive defence.

Telecoms remains the centre of gravity

The technology distribution of the cases is equally revealing. Telecommunications and standards-related disputes accounted for the largest share of the docket. Many involved standard essential patents, codec technologies and licensing programmes associated with mobile communications and connected devices.

The UPC offers SEP owners a potentially powerful enforcement mechanism, while implementers face the prospect of pan-European injunctions and damages claims. Unsurprisingly, the court is increasingly becoming part of the global forum competition surrounding SEP disputes.

At the same time, Chinese-party litigation before the UPC is no longer confined to telecommunications.

Significant numbers of cases arose in manufacturing, consumer electronics, chemicals, semiconductors, medical devices, batteries and solar technologies. Particularly notable is the growing presence of disputes involving energy-transition technologies and advanced manufacturing.

The diversification of technologies appearing before the court suggests that the UPC is becoming relevant to a much broader range of Chinese businesses, not only those operating in traditional SEP-heavy sectors.

Germany remains the primary battleground

Venue selection continues to reflect familiar European patent-litigation dynamics. Munich emerged as the leading UPC division for disputes involving Chinese parties, with Mannheim and Düsseldorf also handling substantial numbers of cases. Together, the German local divisions accounted for the overwhelming majority of the litigation.

This concentration reflects the long-standing experience of the German patent judiciary, the commercial significance of the German market and litigants’willingness to build on enforcement strategies developed before the UPC’s creation.

An equally notable feature of the dataset is that Chinese claimants overwhelmingly chose German divisions when enforcing their own patents.

This suggests that Chinese patentees have rapidly adopted the same forum-selection preferences as established European and US litigants, viewing Munich and Mannheim as the UPC's most influential venues for technology disputes.

Where Chinese-party UPC disputes are heard
Munich
Mannheim &
Düsseldorf
The Hague
Caseload of Chinese-party disputes
Leading
Major
Rising
Chosen by Chinese claimants?
Preferred
Preferred
Rarely

The Hague division also saw increasing involvement of Chinese parties, but Chinese claimants rarely selected it as their preferred venue. Instead, Chinese companies appearing before that division were generally defendants responding to actions brought by others. For in-house counsel and patent owners, the data reinforce the importance of Germany as the central venue for UPC enforcement strategies.

The rise of Chinese claimants

Perhaps the most significant development is the growing number of Chinese companies using the UPC offensively. Twenty of the 97 cases involving Chinese parties were initiated by Chinese claimants. Although Chinese entities remain defendants more often than claimants, the emergence of a meaningful claimant cohort is itself noteworthy.

The data suggest that leading Chinese patent owners increasingly view the UPC as a practical mechanism for enforcing patent rights across Europe.

Companies such as Huawei and Yangtze Memory Technologies are no longer merely defending themselves against foreign rightsholders; they are actively leveraging the UPC to support broader commercial and licensing objectives.

Perhaps the clearest indicator of the UPC’s maturation is the emergence of Chinese-versus-Chinese disputes. Seven of the 20 cases brought by Chinese claimants involved Chinese defendants, spanning telecommunications, electronics, manufacturing and solar technologies.

Historically, many disputes between Chinese companies with international operations might have been litigated primarily before Chinese courts. Their appearance before the UPC suggests that parties increasingly regard the court as a strategically important forum for resolving global competitive conflicts

What the data suggest for 2026 and beyond

The findings point to a broader structural shift in the role of Chinese companies within the international patent system.

First, Chinese businesses are becoming an indispensable part of the UPC ecosystem. Their participation is no longer limited to isolated disputes involving a handful of technology companies.

Second, the court is increasingly being used as a strategic enforcement tool by sophisticated Chinese patent owners seeking Europe-wide remedies.

Third, the expansion of litigation into sectors such as semiconductors, medical devices, batteries and renewable-energy technologies suggests that Chinese involvement in UPC proceedings will continue to diversify beyond telecommunications and SEPs.

For patent owners, implementers and investors, the implication is clear, understanding Chinese litigation behaviour is becoming an essential component of UPC strategy. The most important question is no longer whether Chinese companies will participate in the UPC system, but how rapidly they will expand their use of it as both defendants and rightsholders.

The evidence from the 2025 docket suggests that this transition is already underway.

Chinese companies are no longer participating in the UPC primarily because they are being sued there. Increasingly, they are participating because they regard the court as a valuable strategic asset in their own patent enforcement programmes.

‍

Author: Xiaofan Chen - Partner, Chinese Patent Attorney

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
Quantum IP Strategy: Own control Points, Not Patent Counts
14 October 2026
In quantum, the strongest portfolios will not be the biggest. Stuart Malcolm sets out six moves for owning the control points the market cannot route around, and the questions investors will ask.
#
Consulting
​
Targeted, Not Transformative: The UKIPO’s Considered Course on SEPs
13 October 2026
Andrew Sharples analyses the UKIPO's response to its SEP consultation, exploring proposed changes to FRAND dispute resolution, SEP transparency and licensing guidance, and what they mean for SEP holders and implementers.
#
Consulting
​
Chinese Companies in European Patent Litigation
30 September 2026
Chinese companies are becoming increasingly active in European patent litigation, both as defendants and as patent owners enforcing their own rights. This article examines the growing role of Europe and the Unified Patent Court (UPC) in global patent disputes, highlighting key cases involving Chinese businesses and the strategic opportunities and risks that come with operating in European markets. It is the first in a series exploring the practical implications of European patent enforcement for Chinese companies.
#
Patenting
​
How to mitigate prior art traps for follow-on pharma patents
27 August 2026
Follow-on patents are increasingly important for pharmaceutical innovators. Learn how new EMA clinical trial disclosure rules create prior art risks and discover practical strategies to protect pharmaceutical IP and maximise patent value.
#
Consulting
​
Chinese companies and the UPC: from enforcement targets to strategic users
13 August 2026
Chinese companies are playing an increasingly significant role in UPC litigation, accounting for around 38% of infringement actions in 2025. While many remain defendants, a growing number are actively using the Unified Patent Court to enforce their own patent rights across Europe. The trend highlights the UPC's rising importance for Chinese businesses operating in sectors such as telecommunications, semiconductors, medical devices and renewable energy, and signals a shift in global patent enforcement strategy.
#
Patenting
​
Evaluating the environmental impact of patent AI.
31 July 2026
AI's environmental impact is rarely out of the headlines, but how does it compare to the benefits it delivers in practice? In this article, Laurence Brown examines the energy use of AI-assisted patent drafting, comparing it with traditional drafting workflows. While measuring AI's true environmental footprint is far from straightforward, the analysis suggests that AI-assisted patent drafting may already be more energy efficient, while delivering significant productivity gains for patent professionals.
#
Patenting
​
UPC appeals after three years: Early indications on appeal success rates
15 July 2026
Three years into the UPC, appeal overturn rates sit at 56% for both substantive and preliminary injunction cases, with Kodak v Fujifilm among the rulings reshaping outcomes on appeal.
#
Litigation
​
The UPC After Three Years: From Experiment to Enforcement Forum
15 July 2026
1,282 cases filed at the UPC in three years: infringement actions have surged while revocation filings stayed flat, easing fears the Court would become a European patent graveyard.
#
Litigation
​
Podcast: Building an AI-Native Law Firm
26 June 2026
On the Technically Legal podcast, EIP partner Laurence Brown discusses how Visser AI is redesigning patent workflows, letting the firm offer fixed fees without trading away speed or quality.
#
Patenting
​
Choosing your SEP battleground: UPC, Germany or UK?
07 June 2026
Choosing the right venue for SEP litigation can significantly influence the outcome of FRAND disputes. This article compares the UPC, German and UK courts, examining their approaches to injunctions, FRAND defences, rate-setting and enforcement. It highlights the strategic advantages of each jurisdiction and explains why many SEP owners are increasingly turning to the UK and UPC as part of their European enforcement strategy.
#
Litigation
​
Synthetic Lethality & AI: IP Strategy in Oncology
26 May 2026
This article explores the resurgence of synthetic lethality in precision oncology, highlighting how AI and machine learning are accelerating the discovery of new therapeutic targets. It also examines growing clinical activity, investment, and the evolving intellectual property challenges shaping this emerging field.
#
Consulting
​
Inside the Visser AI Launch Party
20 May 2026
EIP has officially launched Visser AI®, our hybrid intelligence service for patent drafting and prosecution. Watch the launch film from our event at The Boundary in Shoreditch, and discover how our team of European and US patent attorneys — working with the Patently AI platform , delivers faster, lower-cost work at the EPO, USPTO and beyond.
#
Consulting
​
Protecting Your Startup: Five Intellectual Property Mistakes to Avoid
20 May 2026
Early‑stage startups often focus on product development and fundraising, but overlooking intellectual property (IP) can seriously damage long‑term value. This article explores five common IP mistakes startups make, with a particular focus on patents. It covers the risks of filing patents without professional advice, making public disclosures too early, failing to put enforceable contracts in place with third parties, misunderstanding what patent rights actually provide, and neglecting to develop a clear IP strategy. By highlighting these pitfalls and offering practical guidance, the article helps startups protect their innovations, strengthen their commercial position, and improve their prospects with investors.
#
Consulting
​
Technology, Patents, and Sport
13 May 2026
VAR, goal-line tech, AI 3D player avatars, wearable trackers, the technology reshaping the 2026 World Cup and elite sport rests on a patent system that makes the R&D investment behind it worth taking.
#
Patenting
​
Patents or Trade Secrets? When to Patent in Deep Tech Innovation
11 May 2026
Deep tech companies face unique IP challenges due to long development cycles, high upfront investment, and complex technologies that combine products and processes. This article explores when patents, trade secrets, or a combination of both offer the strongest protection. It explains how factors such as detectability, reverse engineering risk, disclosure to third parties, and employee mobility should shape IP strategy decisions. While patents are often best suited to externally visible or licensable technologies, trade secrets can be highly effective for internal processes and know‑how that deliver performance or cost advantages.
#
Patenting
​